LoQus23 Therapeutics

Website

Developer of allosteric small molecule inhibitors targeting MSH3/MutSbeta designed to treat Huntington's disease and other triplet repeat neurodegenerative disorders. The company's therapeutics modula...

Healthcare
Cambridge, United Kingdom
Founded 2019
9 employees
Website
Valuation
$61.4M
Market implied
Share Price
N/A
Total Raised
$67.2M
Last Round
N/A
Investors
+3 other investors
View all 3 investors
Valuation History
0 funding rounds on record
Cap Table
Ownership structure
Market Activity
Secondary transactions

Get the full picture

Create a free account to unlock LoQus23 Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required